Skip to content

Clinical Investigation on the Acoustic Stimulation in the Treatment of Chronic Tinnitus

l Prospective Clinical Investigation on the Acoustic Stimulation With the Coordinated Reset of Neural Subpopulations in the Treatment of Chronic Tinnitus

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00927121
Enrollment
63
Registered
2009-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2012-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Tonal Tinnitus

Brief summary

There are many treatments for chronic tinnitus that have been claimed, with varying degrees of statistical reliability. None of those treatments can eradicate the tinnitus completely. Some therapies can reduce the tinnitus symptoms (loudness, annoyance) up to 30%. Thus there is still a need of new treatments that can reduce considerably the tinnitus symptoms and improve the QOL of subjects. Trial objectives: * The aim of this trial is the improvement of the QOL (quality of live) by reducing the Tinnitus- Symptoms of the patient. * To confirm the efficacy and safety of the coordinated reset technology. These objectives will be assessed: * By subjective and objective measurements of the Tinnitus symptoms, loudness and annoyance.

Interventions

DEVICEAcoustic CR-Stimulator ANM//Technology: Acoustic coordinated reset

The CR-stimulation was originally developed by Prof. Dr. Dr. Peter Tass for deep brain stimulation (DBS). The CR-stimulation through high frequency short pulses causes a neuronal reorganization in the stimulated brain area establishing a normal neuronal activity. Based on intensive modeling studies, experimental proof of concept (POC) animal studies and a clinical POC, we proved that the pathologic activity can be recuperated to a desynchronized/healthy state with the acoustic CR-stimulation. The acoustic CR-stimulation signal will be generated by the ANM CR-Stimulator and transmitted to the ears through a speaker system

Sponsors

ANM Adaptive Neuromodulation GmbH
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mentally healthy people * Chronic tonal Tinnitus * Older than 18 years * Signature of the patient informed consent * No participation in other tinnitus therapy during the clinical investigation

Exclusion criteria

* A necessity for hearing aid * Auditory hallucination * Symptomatic hearing disorders * Morbus Meniere, * Tinnitus due to temporomandibular joint disorders * Subjects who can't perceive therapeutic tones * Brainstem diseases * Psychiatric disorders * Objective Tinnitus * Insufficient treatment of general disorders, anemia, tumor, dialysis, hypertonus ect.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026